| 3005 | 0: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
$49,410,970.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-01 $44,363,939.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-02 $57,726,882.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-03 $53,014,892.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-04 $46,960,495.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-05 $46,180,284.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-06 $55,856,066.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-07 $56,441,120.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-08 $51,359,671.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-09 $54,451,066.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-10 $51,138,372.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-11 $52,119,544.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2009-12 $55,864,007.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-01 $48,985,824.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-02 $56,063,262.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-03 $50,215,656.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-04 $64,968,676.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-05 $62,434,647.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-06 $71,749,910.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-07 $65,208,008.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-08 $63,832,549.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-09 $65,676,867.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-10 $62,598,079.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-11 $66,341,410.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2010-12 $73,188,505.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-01 $55,713,061.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-02 $63,009,076.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-03 $69,487,859.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-04 $78,518,394.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-05 $76,474,126.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-06 $74,989,479.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-07 $66,491,951.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-08 $74,519,725.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-09 $63,660,014.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-10 $68,610,477.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-11 $67,407,565.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2011-12 $74,730,454.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-01 $53,585,357.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-02 $59,690,881.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-03 $64,671,741.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-04 $64,740,225.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-05 $70,369,952.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-06 $70,313,414.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-07 $68,616,895.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-08 $57,873,887.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-09 $70,196,810.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-10 $71,749,626.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-11 $74,422,592.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2012-12 $71,364,061.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2013-01 $64,036,083.00 of HTS Code 3005 — pharmaceutical products imported by the US in 2013-02
| Top 10 suppliers | |
|---|---|
| China | $1,101,966,863 |
| United Kingdom | $364,791,729 |
| Brazil | $315,454,138 |
| Japan | $307,393,392 |
| Finland | $179,872,353 |
| Subscribers only | $139,418,801 |
| Subscribers only | $116,962,497 |
| Switzerland | $93,070,872 |
| Subscribers only | $72,886,025 |
| Subscribers only | $56,282,138 |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
China exported $1,101,966,863.00 of HTS Code 3005 — pharmaceutical products to the US. United Kingdom exported $364,791,729.00 of HTS Code 3005 — pharmaceutical products to the US. Brazil exported $315,454,138.00 of HTS Code 3005 — pharmaceutical products to the US. Japan exported $307,393,392.00 of HTS Code 3005 — pharmaceutical products to the US. Finland exported $179,872,353.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $139,418,801.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $116,962,497.00 of HTS Code 3005 — pharmaceutical products to the US. Switzerland exported $93,070,872.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $72,886,025.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $56,282,138.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $47,502,309.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $43,721,431.00 of HTS Code 3005 — pharmaceutical products to the US. Israel exported $35,579,407.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $29,568,710.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $26,487,991.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $21,609,523.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $20,287,977.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $20,046,958.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $19,397,543.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $16,925,155.00 of HTS Code 3005 — pharmaceutical products to the US. Colombia exported $11,108,358.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $10,152,166.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $9,839,860.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $9,194,564.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $8,535,130.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,678,105.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $7,394,744.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $5,873,661.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $5,494,855.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,971,470.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,009,214.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,940,510.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,884,433.00 of HTS Code 3005 — pharmaceutical products to the US. New Zealand exported $1,275,797.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $822,156.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $786,209.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $738,317.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $629,480.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $490,828.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $333,753.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $252,340.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $226,127.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $192,608.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $155,446.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $65,161.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $26,635.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $24,802.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $18,330.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $17,180.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $14,838.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,884.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,650.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $3,582.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,725.00 of HTS Code 3005 — pharmaceutical products to the US. Georgia exported $2,460.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $2,245.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,142.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $1,110.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $402.00 of HTS Code 3005 — pharmaceutical products to the US. A country, available to Panjiva subscribers, exported $317.00 of HTS Code 3005 — pharmaceutical products to the US.
| Subscribers only | 3.3% |
| Subscribers only | 1.2% |
| Subscribers only | 0.5% |
| Subscribers only | 0.4% |
| Subscribers only | 0.4% |
| Subscribers only | 0.4% |
| Subscribers only | 0.3% |
| Germany | 0.3% |
| Israel | 0.2% |
| Belgium | 0.2% |
| Subscribers only | -2.8% |
| Subscribers only | -2.0% |
| Subscribers only | -0.9% |
| Subscribers only | -0.7% |
| Subscribers only | -0.3% |
| Subscribers only | -0.2% |
| Subscribers only | -0.1% |
| Spain | -0.1% |
| South Africa | -0.1% |
| Taiwan | -0.1% |
Loading chart... (having trouble? make sure you have the Adobe Flash Player installed)
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 3.330%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 1.188%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 0.508%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 0.432%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 0.423%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 0.384%.
A country, available to Panjiva subscribers, increased in shipments of HTS Code 3005 — - to the US by 0.292%.
Germany increased in shipments of HTS Code 3005 — - to the US by 0.281%.
Israel increased in shipments of HTS Code 3005 — - to the US by 0.208%.
Belgium increased in shipments of HTS Code 3005 — - to the US by 0.181%.
Taiwan decreased in shipments of HTS Code 3005 — - to the US by -0.125%.
South Africa decreased in shipments of HTS Code 3005 — - to the US by -0.130%.
Spain decreased in shipments of HTS Code 3005 — - to the US by -0.134%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -0.136%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -0.221%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -0.278%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -0.664%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -0.896%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -1.989%.
A country, available to Panjiva subscribers, decreased in shipments of HTS Code 3005 — - to the US by -2.810%.
| 2009 | 2010 | 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| * | Country | Share | Trend | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All |
100%
|
49,411 | 44,364 | 57,727 | 53,015 | 46,960 | 46,180 | 55,856 | 56,441 | 51,360 | 54,451 | 51,138 | 52,120 | 55,864 | 48,986 | 56,063 | 50,216 | 64,969 | 62,435 | 71,750 | 65,208 | 63,833 | 65,677 | 62,598 | 66,341 | 73,189 | 55,713 | 63,009 | 69,488 | 78,518 | 76,474 | 74,989 | 66,492 | 74,520 | 63,660 | 68,610 | 67,408 | 74,730 | 53,585 | 59,691 | 64,672 | 64,740 | 70,370 | 70,313 | 68,617 | 57,874 | 70,197 | 71,750 | 74,423 | 71,364 | 64,036 | ||||
| 1. | China |
35%
|
19,911 | 13,623 | 14,762 | 17,596 | 16,961 | 14,883 | 16,947 | 17,026 | 17,073 | 17,924 | 16,218 | 17,820 | 19,174 | 13,225 | 15,207 | 14,971 | 18,478 | 20,318 | 21,440 | 24,027 | 20,089 | 21,888 | 20,549 | 22,870 | 28,914 | 23,058 | 19,696 | 26,360 | 28,831 | 27,474 | 26,545 | 25,618 | 24,538 | 22,304 | 22,856 | 26,343 | 29,717 | 18,988 | 20,280 | 23,098 | 26,593 | 25,699 | 29,027 | 25,031 | 29,044 | 25,444 | 24,817 | 30,590 | 30,983 | 27,136 | |||
| 2. | United Kingdom |
12%
|
6,807 | 8,371 | 8,199 | 7,225 | 5,100 | 7,864 | 9,668 | 7,301 | 7,591 | 8,036 | 7,623 | 10,011 | 7,352 | 6,080 | 6,548 | 5,363 | 6,017 | 6,460 | 7,213 | 6,277 | 7,103 | 5,126 | 7,918 | 7,613 | 6,367 | 5,469 | 6,939 | 7,103 | 7,424 | 5,529 | 7,943 | 6,979 | 9,814 | 6,556 | 6,993 | 8,351 | 7,194 | 5,636 | 7,707 | 8,012 | 7,382 | 8,420 | 6,662 | 8,949 | 7,778 | 7,850 | 9,369 | 7,995 | 7,753 | 5,751 | |||
| 3. | Brazil |
10%
|
6,802 | 4,702 | 7,403 | 7,786 | 6,281 | 8,086 | 6,074 | 6,405 | 4,216 | 4,431 | 5,764 | 4,820 | 6,640 | 6,223 | 6,707 | 6,901 | 5,715 | 5,958 | 6,237 | 4,270 | 6,108 | 6,788 | 5,659 | 6,887 | 6,930 | 5,638 | 8,003 | 8,369 | 8,526 | 9,062 | 7,793 | 4,946 | 8,184 | 7,579 | 5,800 | 4,912 | 6,305 | 7,801 | 4,930 | 5,918 | 6,586 | 8,072 | 8,759 | 6,463 | 3,867 | 3,339 | 4,310 | 6,462 | 5,052 | 4,985 | |||
| 4. | Japan |
10%
|
4,928 | 6,629 | 9,748 | 4,579 | 3,282 | 1,973 | 5,470 | 9,785 | 4,837 | 6,238 | 5,829 | 2,075 | 6,319 | 3,334 | 3,421 | 4,647 | 8,277 | 4,886 | 10,196 | 5,126 | 7,014 | 4,680 | 3,046 | 8,928 | 6,853 | 4,262 | 2,919 | 3,368 | 11,462 | 7,442 | 7,159 | 4,137 | 5,944 | 3,027 | 10,238 | 6,169 | 13,907 | 4,165 | 5,427 | 6,163 | 5,161 | 9,515 | 3,832 | 6,541 | 1,447 | 13,202 | 15,761 | 7,972 | 2,764 | 3,314 | |||
| 5. | Finland |
6%
|
1,534 | 1,970 | 3,531 | 2,773 | 2,003 | 2,073 | 2,474 | 2,925 | 2,022 | 2,952 | 2,161 | 3,774 | 1,431 | 3,970 | 3,322 | 1,878 | 6,025 | 2,385 | 4,550 | 4,157 | 3,700 | 2,832 | 3,076 | 2,104 | 6,580 | 4,002 | 5,961 | 6,702 | 5,786 | 7,889 | 5,827 | 5,729 | 7,651 | 6,540 | 5,821 | 1,428 | 1,260 | 1,465 | 1,714 | 2,434 | 2,316 | 1,433 | 2,172 | 2,047 | 2,167 | 2,596 | 1,766 | 2,128 | 8,342 | 8,494 | |||
| 6. | Subscribers only |
4%
|
1,689 | 1,947 | 1,934 | 2,096 | 1,906 | 2,040 | 2,464 | 1,967 | 3,062 | 2,209 | 2,059 | 2,643 | 2,260 | 3,046 | 3,196 | 3,250 | 2,264 | 2,998 | 2,221 | 3,174 | 2,321 | 3,649 | 3,415 | 2,889 | 2,347 | 2,499 | 3,457 | 3,386 | 2,556 | 3,564 | 3,399 | 3,161 | 3,240 | 2,910 | 2,437 | 2,838 | 2,525 | 2,839 | 3,765 | 3,454 | 3,041 | 2,879 | 2,910 | 3,941 | 3,069 | 3,897 | 2,739 | 2,647 | 2,662 | 2,558 | |||
| 7. | Subscribers only |
4%
|
1,040 | 1,599 | 1,416 | 2,328 | 1,206 | 1,325 | 1,785 | 2,095 | 2,229 | 2,190 | 2,006 | 2,015 | 1,904 | 1,963 | 1,745 | 1,867 | 1,959 | 2,253 | 1,658 | 2,240 | 1,665 | 2,125 | 2,108 | 2,343 | 1,839 | 2,108 | 2,957 | 2,552 | 2,094 | 2,561 | 2,154 | 2,318 | 2,244 | 2,441 | 4,006 | 3,258 | 3,103 | 3,200 | 3,542 | 2,566 | 2,569 | 2,674 | 2,696 | 3,254 | 2,615 | 3,405 | 2,906 | 2,762 | 3,321 | 2,753 | |||
| 8. | Switzerland |
3%
|
120 | 81 | 951 | 1,464 | 1,100 | 1,216 | 1,587 | 1,282 | 1,207 | 487 | 106 | 108 | 89 | 116 | 52 | 42 | 132 | 2,005 | 2,429 | 3,656 | 1,944 | 2,194 | 3,308 | 2,969 | 4,125 | 2,275 | 2,715 | 2,317 | 3,016 | 2,939 | 4,244 | 2,433 | 2,331 | 2,614 | 1,699 | 3,594 | 1,782 | 2,465 | 2,859 | 2,275 | 2,149 | 2,728 | 2,512 | 2,495 | 1,279 | 1,513 | 1,584 | 3,158 | 1,462 | 1,862 | |||
| 9. | Subscribers only |
2%
|
261 | 981 | 2,181 | 1,252 | 1,161 | 1,210 | 1,641 | 1,343 | 1,684 | 1,516 | 1,749 | 1,258 | 1,168 | 1,698 | 1,328 | 1,300 | 1,409 | 1,641 | 1,774 | 2,579 | 1,545 | 1,636 | 1,752 | 2,371 | 1,141 | 727 | 2,203 | 1,244 | 2,126 | 2,214 | 1,888 | 2,567 | 2,221 | 2,171 | 1,615 | 1,061 | 958 | 941 | 1,696 | 1,760 | 1,117 | 790 | 1,519 | 1,030 | 583 | 1,245 | 1,114 | 915 | 785 | 816 | |||
| 10. | Subscribers only |
2%
|
0.79 | 18 | 77 | 37 | 57 | 0 | 13 | 0 | 27 | 28 | 39 | 168 | 1,438 | 3,130 | 7,022 | 3,488 | 5,587 | 5,514 | 5,987 | 2,973 | 4,230 | 8,544 | 4,975 | 0 | 64 | 0 | 0 | 6.42 | 0 | 3.66 | 40 | 208 | 1,040 | 409 | 331 | 278 | 275 | 0 | 16 | 45 | 58 | 0 | 4.30 | 34 | 0 | 0 | 0 | 0 | 113 | 3.06 | |||
| 11. | Subscribers only |
2%
|
986 | 842 | 1,098 | 989 | 2,168 | 752 | 1,270 | 1,240 | 1,456 | 2,193 | 1,643 | 1,097 | 1,351 | 872 | 1,162 | 1,001 | 1,262 | 877 | 978 | 911 | 1,307 | 709 | 574 | 681 | 513 | 570 | 550 | 659 | 725 | 888 | 605 | 682 | 699 | 697 | 713 | 671 | 636 | 912 | 762 | 1,172 | 972 | 931 | 921 | 833 | 588 | 780 | 738 | 949 | 1,283 | 634 | |||
| 12. | Subscribers only |
1%
|
198 | 399 | 483 | 284 | 824 | 361 | 514 | 198 | 765 | 1,104 | 827 | 1,312 | 829 | 816 | 1,304 | 637 | 683 | 1,467 | 1,216 | 514 | 969 | 745 | 1,082 | 713 | 1,056 | 639 | 964 | 1,494 | 708 | 1,452 | 808 | 1,039 | 1,130 | 695 | 664 | 1,024 | 1,126 | 783 | 866 | 1,382 | 1,035 | 991 | 1,199 | 1,189 | 312 | 1,167 | 378 | 1,015 | 1,234 | 1,129 | |||
| 13. | Israel |
1%
|
1,247 | 281 | 813 | 291 | 694 | 736 | 808 | 810 | 1,069 | 802 | 414 | 853 | 786 | 388 | 539 | 328 | 792 | 722 | 807 | 413 | 647 | 684 | 819 | 713 | 975 | 459 | 362 | 482 | 556 | 410 | 736 | 825 | 1,003 | 719 | 828 | 667 | 1,003 | 529 | 1,040 | 413 | 925 | 573 | 1,217 | 854 | 921 | 381 | 847 | 1,039 | 757 | 605 | |||
| 14. | Subscribers only |
1%
|
162 | 282 | 370 | 362 | 317 | 263 | 244 | 322 | 141 | 275 | 136 | 321 | 215 | 272 | 238 | 537 | 811 | 1,011 | 484 | 263 | 346 | 279 | 119 | 149 | 389 | 7.98 | 795 | 950 | 941 | 755 | 671 | 1,385 | 598 | 804 | 427 | 1,027 | 1,300 | 382 | 1,073 | 963 | 764 | 990 | 1,246 | 885 | 673 | 851 | 720 | 1,628 | 918 | 507 | |||
| 15. | Subscribers only |
1%
|
327 | 563 | 414 | 510 | 601 | 683 | 599 | 536 | 881 | 358 | 659 | 897 | 847 | 544 | 563 | 829 | 538 | 558 | 555 | 588 | 441 | 450 | 458 | 645 | 534 | 386 | 280 | 300 | 469 | 469 | 288 | 526 | 857 | 437 | 648 | 373 | 132 | 643 | 532 | 636 | 565 | 671 | 472 | 728 | 388 | 535 | 579 | 569 | 144 | 284 | |||
| 16. | Subscribers only |
1%
|
23 | 18 | 477 | 599 | 404 | 294 | 820 | 187 | 336 | 630 | 316 | 312 | 565 | 115 | 313 | 230 | 1,117 | 126 | 483 | 504 | 633 | 294 | 251 | 342 | 717 | 181 | 796 | 498 | 536 | 171 | 803 | 811 | 325 | 856 | 330 | 442 | 207 | 502 | 323 | 669 | 603 | 138 | 693 | 253 | 339 | 296 | 462 | 500 | 657 | 114 | |||
| 17. | Subscribers only |
1%
|
167 | 243 | 493 | 209 | 416 | 506 | 329 | 283 | 388 | 237 | 441 | 210 | 523 | 270 | 427 | 341 | 616 | 368 | 337 | 408 | 694 | 438 | 434 | 823 | 395 | 326 | 485 | 197 | 472 | 474 | 371 | 698 | 423 | 609 | 526 | 569 | 591 | 197 | 581 | 200 | 582 | 407 | 224 | 297 | 354 | 185 | 322 | 377 | 417 | 410 | |||
| 18. | Subscribers only |
1%
|
1,142 | 385 | 794 | 551 | 424 | 244 | 439 | 433 | 407 | 563 | 391 | 431 | 565 | 443 | 861 | 429 | 376 | 257 | 329 | 391 | 493 | 339 | 345 | 438 | 374 | 120 | 434 | 517 | 361 | 433 | 420 | 253 | 189 | 315 | 271 | 149 | 169 | 490 | 346 | 321 | 334 | 251 | 413 | 354 | 513 | 287 | 428 | 221 | 312 | 300 | |||
| 19. | Subscribers only |
1%
|
330 | 422 | 294 | 596 | 366 | 351 | 829 | 293 | 296 | 446 | 189 | 83 | 164 | 382 | 349 | 531 | 360 | 556 | 387 | 300 | 578 | 381 | 645 | 448 | 565 | 1,189 | 660 | 456 | 27 | 387 | 722 | 269 | 67 | 32 | 53 | 1,478 | 176 | 268 | 366 | 596 | 419 | 240 | 415 | 70 | 136 | 2.58 | 77 | 52 | 419 | 680 | |||
| 20. | Subscribers only |
1%
|
240 | 93 | 313 | 105 | 562 | 50 | 333 | 354 | 172 | 290 | 403 | 302 | 337 | 192 | 115 | 166 | 600 | 451 | 6.38 | 349 | 481 | 38 | 126 | 69 | 206 | 359 | 144 | 374 | 158 | 398 | 488 | 129 | 115 | 393 | 289 | 323 | 206 | 82 | 81 | 497 | 211 | 364 | 1,031 | 1,320 | 68 | 1,425 | 368 | 1,060 | 546 | 147 | |||
| 21. | Colombia |
<1%
|
350 | 73 | 244 | 260 | 186 | 175 | 1.78 | 250 | 309 | 207 | 143 | 272 | 226 | 253 | 400 | 226 | 463 | 245 | 367 | 18 | 136 | 129 | 88 | 519 | 345 | 0 | 370 | 100 | 178 | 305 | 114 | 302 | 168 | 245 | 0 | 352 | 214 | 94 | 191 | 179 | 90 | 357 | 471 | 177 | 0 | 466 | 217 | 282 | 179 | 172 | |||
| 22. | Subscribers only |
<1%
|
91 | 1.38 | 102 | 52 | 73 | 11 | 100 | 24 | 78 | 70 | 118 | 16 | 109 | 81 | 44 | 139 | 308 | 186 | 385 | 196 | 243 | 291 | 444 | 201 | 331 | 226 | 339 | 605 | 248 | 144 | 293 | 253 | 131 | 210 | 430 | 627 | 181 | 209 | 178 | 383 | 85 | 100 | 133 | 443 | 210 | 163 | 189 | 203 | 244 | 229 | |||
| 23. | Subscribers only |
<1%
|
196 | 204 | 350 | 236 | 103 | 185 | 192 | 129 | 264 | 105 | 274 | 374 | 157 | 184 | 155 | 201 | 176 | 216 | 122 | 247 | 130 | 244 | 380 | 326 | 260 | 12 | 455 | 84 | 164 | 165 | 226 | 276 | 221 | 114 | 376 | 330 | 220 | 160 | 322 | 90 | 234 | 233 | 352 | 127 | 47 | 36 | 56 | 39 | 34 | 58 | |||
| 24. | Subscribers only |
<1%
|
52 | 73 | 183 | 278 | 102 | 184 | 95 | 143 | 4.32 | 168 | 195 | 20 | 101 | 365 | 6.30 | 0 | 0 | 0 | 239 | 182 | 134 | 0 | 2.38 | 246 | 196 | 278 | 125 | 93 | 234 | 173 | 315 | 92 | 337 | 185 | 115 | 209 | 307 | 146 | 159 | 551 | 7.03 | 927 | 279 | 289 | 63 | 184 | 323 | 208 | 250 | 377 | |||
| 25. | Subscribers only |
<1%
|
60 | 14 | 395 | 129 | 72 | 114 | 155 | 543 | 252 | 178 | 524 | 62 | 394 | 326 | 206 | 250 | 250 | 280 | 358 | 401 | 227 | 209 | 83 | 161 | 43 | 433 | 273 | 391 | 266 | 187 | 159 | 98 | 103 | 64 | 231 | 168 | 151 | 40 | 38 | 0 | 35 | 20 | 110 | 0 | 0 | 0 | 0 | 0 | 80 | 0 | |||
| 26. | Subscribers only |
<1%
|
42 | 58 | 86 | 51 | 65 | 100 | 70 | 60 | 57 | 53 | 103 | 128 | 46 | 76 | 157 | 94 | 65 | 140 | 102 | 267 | 154 | 90 | 438 | 158 | 337 | 79 | 532 | 79 | 85 | 140 | 258 | 65 | 304 | 244 | 258 | 143 | 109 | 90 | 129 | 148 | 113 | 137 | 130 | 146 | 244 | 135 | 383 | 253 | 200 | 274 | |||
| 27. | Subscribers only |
<1%
|
222 | 118 | 213 | 142 | 92 | 140 | 142 | 112 | 137 | 267 | 201 | 164 | 230 | 45 | 46 | 157 | 138 | 115 | 138 | 142 | 179 | 186 | 48 | 289 | 228 | 127 | 136 | 136 | 229 | 289 | 197 | 67 | 148 | 119 | 44 | 203 | 266 | 77 | 99 | 129 | 5.16 | 49 | 174 | 80 | 348 | 75 | 193 | 261 | 52 | 0 | |||
| 28. | Subscribers only |
<1%
|
200 | 53 | 0 | 49 | 146 | 6.79 | 265 | 69 | 126 | 70 | 122 | 145 | 305 | 0 | 121 | 175 | 127 | 83 | 50 | 285 | 102 | 85 | 169 | 140 | 98 | 0 | 0 | 294 | 4.20 | 206 | 129 | 74 | 75 | 147 | 175 | 131 | 148 | 99 | 134 | 190 | 0 | 194 | 147 | 185 | 98 | 144 | 104 | 7.69 | 99 | 95 | |||
| 29. | Subscribers only |
<1%
|
17 | 18 | 12 | 28 | 20 | 25 | 16 | 14 | 16 | 21 | 31 | 37 | 45 | 263 | 92 | 93 | 2.41 | 11 | 9.56 | 90 | 27 | 4.18 | 0 | 29 | 10 | 15 | 30 | 55 | 28 | 41 | 57 | 18 | 65 | 12 | 51 | 43 | 80 | 55 | 187 | 63 | 315 | 176 | 271 | 198 | 538 | 362 | 728 | 994 | 98 | 83 | |||
| 30. | Subscribers only |
<1%
|
112 | 68 | 59 | 76 | 121 | 106 | 113 | 93 | 118 | 79 | 84 | 93 | 65 | 94 | 91 | 56 | 72 | 78 | 84 | 89 | 80 | 83 | 113 | 77 | 78 | 67 | 115 | 76 | 100 | 102 | 90 | 115 | 83 | 69 | 110 | 75 | 98 | 87 | 99 | 87 | 99 | 116 | 74 | 83 | 14 | 0 | 0 | 3.29 | 22 | 0 | |||
| 31. | Subscribers only |
<1%
|
80 | 80 | 0 | 0 | 75 | 0 | 0 | 54 | 75 | 75 | 140 | 0 | 70 | 70 | 70 | 0 | 140 | 70 | 0 | 70 | 70 | 73 | 0 | 35 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 153 | 76 | 2.79 | 161 | 79 | 4.91 | 73 | 90 | 79 | 50 | 117 | 75 | 73 | 0 | 76 | 74 | 0 | 0 | 67 | |||
| 32. | Subscribers only |
<1%
|
51 | 132 | 278 | 55 | 14 | 119 | 157 | 82 | 9.32 | 161 | 157 | 145 | 68 | 77 | 116 | 0 | 21 | 36 | 0 | 4.74 | 0 | 14 | 12 | 3.99 | 115 | 4.43 | 4.37 | 7.73 | 0 | 0 | 0 | 0 | 6.36 | 0 | 2.54 | 5.25 | 68 | 0 | 0 | 6.50 | 6.55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 33. | Subscribers only |
<1%
|
0.74 | 0 | 0 | 0 | 1.06 | 7.93 | 9.92 | 4.46 | 31 | 47 | 7.26 | 18 | 33 | 0 | 68 | 32 | 0 | 75 | 70 | 56 | 33 | 38 | 78 | 114 | 90 | 64 | 31 | 70 | 11 | 49 | 8.75 | 56 | 15 | 0 | 17 | 17 | 23 | 20 | 24 | 33 | 69 | 2.36 | 59 | 153 | 45 | 38 | 81 | 88 | 45 | 49 | |||
| 34. | New Zealand |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41 | 27 | 33 | 29 | 37 | 143 | 8.84 | 0 | 51 | 59 | 30 | 56 | 45 | 33 | 32 | 67 | 47 | 70 | 57 | 0 | 8.10 | 12 | 0 | 179 | 50 | 0 | 0 | 14 | 0 | 0 | 0 | 13 | 34 | 24 | 0 | 46 | 29 | |||
| 35. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.81 | 0 | 0 | 0 | 0 | 338 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | 0 | 0 | 0 | 0 | 87 | 128 | 89 | 33 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.60 | 0 | |||
| 36. | Subscribers only |
<1%
|
0.87 | 2.20 | 0 | 1.20 | 3.33 | 0 | 0 | 0.27 | 0.94 | 0.30 | 0 | 28 | 0 | 0 | 0 | 5.82 | 31 | 13 | 0 | 7.03 | 0 | 11 | 3.87 | 0 | 21 | 2.63 | 30 | 23 | 31 | 4.91 | 23 | 11 | 15 | 22 | 15 | 16 | 30 | 39 | 9.90 | 48 | 67 | 18 | 24 | 80 | 35 | 25 | 17 | 23 | 39 | 7.53 | |||
| 37. | Subscribers only |
<1%
|
15 | 5.30 | 3.88 | 9.85 | 14 | 9.37 | 14 | 15 | 6.13 | 14 | 8.24 | 9.74 | 7.10 | 17 | 12 | 11 | 18 | 16 | 7.56 | 10 | 0 | 9.05 | 15 | 0 | 3.88 | 3.01 | 5.88 | 4.90 | 5.10 | 6.72 | 19 | 13 | 3.61 | 0 | 4.87 | 2.13 | 23 | 2.04 | 4.64 | 8.76 | 149 | 139 | 16 | 4.96 | 5.48 | 15 | 24 | 17 | 0 | 12 | |||
| 38. | Subscribers only |
<1%
|
0 | 0 | 28 | 0.82 | 33 | 5.68 | 38 | 41 | 7.19 | 0 | 35 | 88 | 0 | 0 | 0 | 0 | 62 | 16 | 39 | 0 | 0 | 8.85 | 0 | 0 | 14 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 23 | 7.82 | 40 | 0 | 4.07 | 0 | 12 | 0 | 19 | 14 | 28 | 0 | 0 | 34 | |||
| 39. | Subscribers only |
<1%
|
0.56 | 5.52 | 0 | 2.24 | 4.36 | 7.70 | 35 | 4.04 | 9.58 | 6.28 | 2.38 | 1.50 | 0 | 7.88 | 0 | 0 | 32 | 0 | 2.20 | 3.04 | 4.75 | 0 | 4.96 | 9.50 | 2.51 | 0 | 38 | 4.65 | 0 | 7.72 | 6.55 | 38 | 0 | 13 | 26 | 0 | 0 | 36 | 10 | 73 | 0 | 13 | 9.24 | 4.69 | 0 | 9.14 | 6.78 | 0 | 44 | 5.00 | |||
| 40. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 41. | Subscribers only |
<1%
|
1.36 | 3.42 | 6.65 | 2.02 | 0 | 0 | 4.10 | 5.57 | 0 | 18 | 0.60 | 0.31 | 49 | 0 | 0 | 0 | 6.23 | 2.32 | 5.13 | 0 | 0 | 0 | 0 | 0 | 0 | 7.81 | 12 | 0 | 2.22 | 0 | 25 | 0 | 0 | 4.08 | 0 | 0 | 30 | 0 | 8.95 | 0 | 0 | 0 | 2.61 | 0 | 0 | 6.14 | 11 | 0 | 0 | 38 | |||
| 42. | Subscribers only |
<1%
|
0.32 | 0 | 0 | 0.32 | 1.64 | 0 | 0 | 0.91 | 0 | 0.62 | 2.33 | 0.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.07 | 2.34 | 0 | 0 | 11 | 63 | 13 | 15 | 4.02 | 44 | 3.46 | 44 | 0 | 5.33 | 7.43 | 3.92 | 0 | |||
| 43. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 55 | 137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 44. | Subscribers only |
<1%
|
1.15 | 0 | 4.45 | 5.31 | 0 | 9.48 | 0 | 8.01 | 0 | 0 | 15 | 2.83 | 0 | 0 | 9.37 | 0 | 8.30 | 6.53 | 0 | 11 | 5.36 | 0 | 0 | 7.14 | 0 | 0 | 0 | 11 | 0 | 9.42 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.36 | 0 | 0 | 12 | 0 | 0 | 0 | 8.69 | |||
| 45. | Subscribers only |
<1%
|
0 | 0.70 | 0.93 | 4.40 | 0 | 4.47 | 0 | 0.96 | 0 | 0 | 2.76 | 1.50 | 0 | 0 | 0 | 3.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.70 | 0 | 0 | 0 | 12 | 0 | 6.10 | 0 | 0 | 8.32 | 0 | 0 | 2.74 | 0 | 2.74 | 0 | 3.91 | 0 | 0 | 3.73 | 0 | 0 | 0 | 0 | 0 | 0 | 4.18 | |||
| 46. | Subscribers only |
<1%
|
0 | 3.82 | 7.47 | 0.26 | 0 | 0 | 0 | 0.42 | 0 | 0.42 | 0 | 5.34 | 0 | 0 | 3.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.25 | 2.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 47. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 2.45 | 9.95 | 0 | 0 | 0 | 0 | 0 | |||
| 48. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 49. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | |||
| 50. | Subscribers only |
<1%
|
1.17 | 0.68 | 1.81 | 0.50 | 0 | 0.30 | 0.75 | 0.32 | 0.85 | 0 | 0 | 0.95 | 0 | 0 | 2.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 51. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 52. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 3.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 53. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.58 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 54. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 2.73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 55. | Georgia |
<1%
|
0 | 0 | 2.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 56. | Subscribers only |
<1%
|
2.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 57. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 58. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0 | 0 | 1.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 59. | Subscribers only |
<1%
|
0 | 0.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 60. | Subscribers only |
<1%
|
0 | 0 | 0 | 0 | 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Import | Export | Description |
|---|---|---|
| 30 | 30 | Pharmaceutical products |
| 3001 | 3001 | 0: Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included |
| 3002 | 3002 | Pharmaceutical products: Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: |
| 3003 | 3003 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale |
| 3004 | 3004 | 0: Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
| 3005 | 3005 | 0: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
| 3005.10 | 3005.10 | Pharmaceutical products: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
| 3005.90 | 3005.90 | Pharmaceutical products: Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes |
| 3006 | 3006 | 0: Pharmaceutical goods specified in note 4 to this chapter |